LONDON Executives from Vodafone and CK Hutchison's Three UK unit said their 15 billion pound ($18 billion) merger

Elon Musk’s brain chip company Neuralink said on Thursday that it now has regulatory approval in the US to test its implants in human subjects. Neuralink has been building chips to be implanted into the skull for a brain-computer interface, claiming their development has the potential to help restore vision in the blind, and even help paralysed people walk again. While Mr Musk has said on several occasions since 2019 that the company is ready to go for experiments in humans to treat paralysis and blindness, the US Food and Drug Administration (FDA) had however rejected proposals by the company to begin human clinical trials. For instance, in early 2022, when Neuralink applied for human testing, the FDA rejected the proposal saying there were “dozens of issues the company must address”. These issues flagged by the FDA included the use of lithium batteries in Neuralink’s device and the likelihood of the implant’s wires interfering with the brain. The federal agency also expressed concerns about whether the firm’s implants can be removed without causing brain damage. Neuralink has also come under the scanner of at least one US government probe after animal rights watchdogs accused the firm of “inadequate care” of its research monkeys. Reuters previously reported that the brain chip company killed about 1,500 animals, including over 280 sheep, pigs and monkeys since 2018. The US Department of Agriculture also began investigating Neuralink’s potential violations of the Animal Welfare Act. Responding to the animal abuse complaints, the company said in a blogpost that it was “absolutely committed to working with animals in the most humane and ethical way possible”. “The use of every animal was extensively planned and considered to balance scientific discovery with the ethical use of animals,” it said. In a tweet in November last year, Mr Musk said he was confident that Neuralink’s device was “ready for humans”, adding that the timing for beginning human trials was a “function of working through the FDA approval process”. “We want to be extremely careful and certain that it will work well before putting a device into a human but we’ve submitted I think most of our paperwork to the FDA and probably in about six months we should be able to upload Neuralink in a human,” the Tesla and SpaceX chief said. On Thursday, the company said it has finally received approval from the federal agency to begin trials in humans. “We are excited to share that we have received the FDA’s approval to launch our first-in-human clinical study!” the brain chip company said. The FDA approval “represents an important first step that will one day allow our technology to help many people”, Neuralink said, adding that it would soon announce more information on the recruitment of people for clinical trials. FDA hasn’t immediately responded to The Independent‘s queries on the Neuralink approval claim. Read More What is superintelligence? How AI could replace humans as the dominant lifeform on Earth Elon Musk’s Neuralink probed over shipment of ‘contaminated’ devices from ‘infected’ monkey brains When sci-fi becomes reality: could brain-machine interfaces be right around the corner?

SUNNYVALE, Calif.--(BUSINESS WIRE)--Sep 21, 2023--

Living modestly space-wise doesn't rule out the convenience of outsourcing chores where you can. Actually,

Apple Inc. will issue an update for the iPhone 12 “in the coming days” in response to a

FARMINGTON, Conn.--(BUSINESS WIRE)--Jun 27, 2023--

The Mona Lisa has been the subject of awe and fascination for centuries, with experts from around the world desperate to solve the mystery behind her iconic, enigmatic smile. Now, thanks to X-ray technology, scientists have begun to uncover the secrets of Leonardo da Vinci’s legendary portrait, and explain how he was able to create something so mind-bending with just a few strokes of a brush. The research, published in the Journal of the American Chemical Society on Wednesday, suggests that the Italian Renaissance master may have been in a particularly inventive mood when set about crafting the piece in the early 16th century. "He was someone who loved to experiment, and each of his paintings is completely different technically," Victor Gonzalez, the study's lead author, told the Associated Press.. Gonzalez, who has studied the chemical compositions of dozens of works by Leonardo and other artists, discovered that there was something special about the paint used for the Mona Lisa. Specifically, the researchers found a rare compound, called plumbonacrite, in Leonardo's first layer of paint. The discovery confirmed that Leonardo most likely used lead oxide powder to thicken and help dry his paint as he began working on the portrait. He is thought to have dried the powder, which has an orange colour, in linseed or walnut oil by heating the mixture to make a thicker, faster-drying paste. "What you will obtain is an oil that has a very nice golden colour," Gonzalez said. "It flows more like honey." Carmen Bambach, a specialist in Italian art and curator at New York's Metropolitan Museum of Art, who was not involved in the study, called the research "very exciting". She emphasised that any scientifically proven new insights into Leonardo's painting techniques are "extremely important news for the art world and our larger global society." Finding plumbonacrite in the Mona Lisa attests "to Leonardo's spirit of passionate and constant experimentation as a painter—it is what renders him timeless and modern," Bambach said. The paint fragment Gonzalez and his team analysed for their study was taken from the base layer of the painting and was barely visible to the naked eye. It was no larger than the diameter of a human hair, and came from the top right-hand edge of the picture that now takes pride of place in Paris’s Louvre Museum. The scientists peered into the sample’s atomic structure using X-rays in a synchrotron – a large machine that accelerates particles to almost the speed of light. This allowed them to unravel the speck's chemical makeup and detect the plumbonacrite. The compound is a byproduct of lead oxide, allowing the researchers to say with more certainty that Leonardo likely used the powder in his paint recipe. "Plumbonacrite is really a fingerprint of his recipe," Gonzalez said. "It's the first time we can actually chemically confirm it." After Leonardo, Dutch master Rembrandt may have used a similar recipe when he was painting in the 17th century; Gonzalez and other researchers have previously found plumbonacrite in his work, too. "It tells us also that those recipes were passed on for centuries," Gonzalez said. "It was a very good recipe." Still, the ‘Mona Lisa’—said by the Louvre to be a portrait of Lisa Gherardini, the wife of a Florentine silk merchant—and other works by Leonardo still have other secrets to tell. "There are plenty, plenty more things to discover, for sure,” Gonzalez said. “We are barely scratching the surface.” Sign up for our free Indy100 weekly newsletter Have your say in our news democracy. Click the upvote icon at the top of the page to help raise this article through the indy100 rankings.

Norfolk Southern believes a software defect — not a hacker — was the cause of the widespread computer outage that forced the railroad to park all of its trains for most of Monday

Ice Poseidon's act of planting a giant Kick flag on Mount Everest serves as an endorsement for the growing streaming platform

SANTA MONICA, Calif.--(BUSINESS WIRE)--Aug 30, 2023--

The PlayStation 5 and Xbox Series X/S come stacked with several exciting and powerful features,

The best left-backs to sign on Football Manager 2024, including Valentin Barco, Ferland Mendy, Lucas Digne & more.